X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Quarterly Results   (SUNP)

Here are the latest quarterly results of Sun Pharma. For more details, see the Sun Pharma financial fact sheet and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Sun Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m76,34282,43082,65179,12771,37062,08866,50366,532 
Other income Rs m-3501,5711,1941,2222,2451,5202,5481,292 
Turnover Rs m75,99284,00183,84580,34873,61563,60869,05267,824 
Expenses Rs m51,22953,22050,97454,59555,89551,13152,74751,999 
Gross profit Rs m22,72126,79929,14924,53115,8851,45213,75614,534 
Depreciation Rs m2,6433,1603,0383,0683,3823,4663,5873,393 
Interest Rs m8861,3465371,6654501,0941,574953 
Profit before tax Rs m18,84323,86426,76821,02014,299-1,58911,14411,479 
Tax Rs m1,7063,5274,4173,729443-1,6181,1147,487 
Profit after tax Rs m17,13720,33722,35117,29113,8562910,0303,992 
Gross profit margin %29.832.535.331.022.32.320.721.8 
Effective tax rate %9.114.816.517.73.1101.810.065.2 
Net profit margin %22.424.727.021.919.40.015.16.0 
Diluted EPS Rs 7.1 8.5 9.3 7.2 5.8 0.0 4.2 1.7  
Diluted EPS (TTM) Rs 22.4 26.1 30.7 32.0 30.7 22.2 17.1 11.6  
 Subscriber Feature View View View View View View View    
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   ALEMBIC LTD  VENUS REMEDIES  PFIZER  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare SUN PHARMA With:   ALEMBIC LTD  VENUS REMEDIES  PFIZER  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Flat; Oil & Gas Sector Down 2.3%(12:30 pm)

Share markets in India are presently trading near the dotted line. Sectoral indices are trading on a mixed note with stocks in the metal sector.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


May 23, 2018 03:35 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - MERCK LTD COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS